Name: Tocilizumab,Atlizumab
Brand name: Actemra,RoActemra
CAS NO.: 375823-41-9
Package: 2mg/tube；5mg/tube；10mg/tube；20mg/tube；50mg/tube；
CAT. NO.: TM-Toci-00002;TM-Toci-00005;TM-Toci-00010;TM-Toci-00020;TM-Toci-00050;
Price: Inquiry
Stock: In Stock 

Storage: Stored at -75 ± 10℃for long-term storage,≤ -20℃for short-term storage, away from light. 

 

Remark: For R&D Only.

 
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Tocilizumab
 

TheraMabs is a leading manufacturing and exporting biopharmaceutical company in therapeutic Mabs and fusion protein products in China. As an innovation-driven and customer-focused company, TheraMabs provides a broad and integrated portfolio of services throughout the therapeutic Mabs and fusion proteins R&D process. Our services are designed to help our customers shorten the discovery and development time and lower the cost of drug and medical device through cost-effective and efficient outsourcing solutions. TheraMabs has successfully established a fully integrated services and technology platform. The company built its initial capabilities around bio-process research, process development services, formulation, and biologics manufacturing services, antibody and biological research reagent manufacturing and sales and regulatory services.
We have provided many excellent products and services to lots of biopharmaceutical companies not only across China but also in many European, American and south-east Asia countries. We are striving to offer all our customers excellent products, considerate services and competitive price.